ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag universal flu vaccine ecology culture

A fruit bat in the hands of a researcher
How an Early Warning Radar Could Prevent Future Pandemics
Amos Zeeberg, Undark | Feb 27, 2023 | 8 min read
Metagenomic sequencing can help detect unknown pathogens, but its widespread use faces challenges.
Science with Borders: Researchers Navigate Red Tape
Max Kozlov | Mar 1, 2021 | 10 min read
Scientists who work with foreign biological specimens face a patchwork of permits that threaten to block their projects, with potentially harmful consequences for the ecosystems they study.
Updated July 9
Track COVID-19 Vaccines Advancing Through Clinical Trials
The Scientist | Apr 7, 2020 | 10+ min read
Find the latest updates in this one-stop resource, including efficacy data and side effects of approved shots, as well as progress on new candidates entering human studies.
Vaccines: Victims of Their Own Success?
Ricki Lewis | Jul 18, 2004 | 10+ min read
Perhaps in no area is the divide between the developed and developing worlds as striking as it is for vaccines: While healthcare consumers in economically advantaged nations worry about risk, in developing nations compelling need forces a focus on potential benefit. "People in the United States want a quick solution, not prevention, so they prefer drugs to vaccines. Elsewhere, people are afraid of drugs and side effects, and prefer vaccines," says Shan Lu, a primary-care physician who has worked
Updated Sept 1
coronavirus pandemic news articles covid-19 sars-cov-2 virology research science
Follow the Coronavirus Outbreak
The Scientist | Feb 20, 2020 | 10+ min read
Saliva tests screen staff and students at University of Illinois; Study ranks species most susceptible to SARS-CoV-2 infection; COVID-19 clinical trials test drugs that inhibit kinin system
TSG101: An Antiviral Target with a Murky Past
Ricki Lewis | Jan 18, 2004 | 5 min read
Viruses hijack a host protein that normally sorts the trash
Anthrax attacks highlight holes in US public health system
Janis Kelly(jckelly@lightlink.com) | Nov 21, 2001 | 5 min read
The bioterrorist activity in the United States has identified significant gaps in the supposed seamless and coherent response to major public health emergencies.
Researchers Finding Rewarding Careers As Software Entrepreneurs
Karen Hopkin | Jul 7, 1996 | 10 min read
Bacterium SIZE MATTERS: Deer ticks -- vectors of Borrelia Burgdorferi -- are half the size of the common dog tick, which is not associated with Lyme disease. As a new generation of adolescent deer tick enjoys its first blood meal, scientists in the United States and abroad continue to focus their research efforts on understanding and preventing Lyme disease. Ticks infected with the bacterium Borrelia burgdorferi cause more than 10,000 cases of Lyme disease in the U.S. each year, according to
Biological Terrorism
Jennifer Fisher Wilson | Nov 11, 2001 | 8 min read
One warning came in black-and-white in 1993: A U.S. Congressional Office of Technology Assessment report projected that releasing 100 kilograms of aerosolized anthrax spores upwind of the U.S. capital could kill between 130,000 and 3 million people-a lethality at least matching that of a hydrogen bomb. Last year, a U.S. Justice Department exercise revealed that discharging pneumonic plague in Denver could create 3,700 or more cases, with an estimated 950 or more deaths within a week.1 Then, acco
African Sleeping Sickness: A Recurring Epidemic
Ricki Lewis | May 12, 2002 | 5 min read
African trypanosomiasis is making an unwelcome comeback. But unlike other returning diseases, this one has a drug treatment—eflornithine—that disappeared from the market when it failed to cure cancer. Yet like Viagra's origin from a curious side effect in a clinical trial, so too was eflornithine reborn. "When it was discovered that it removes mustaches in women, it suddenly had a market: western women with mustaches," says Morten Rostrup, president of the international council for M

Run a Search

ADVERTISEMENT